HRMY
NASDAQ · Pharmaceuticals
Harmony Biosciences Holdings
$42.02
-0.72 (-1.68%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+31.03%
YTD
+12.41%
Open$42.57
Previous Close$42.74
Day High$43.27
Day Low$41.90
52W High$43.49
52W Low$25.52
Volume—
Avg Volume1.10M
Market Cap2.49B
P/E Ratio13.73
EPS$3.09
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$37.42
Above
SMA 200
$34.21
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
17 analysts
Price Target
+122.6% upside
Current
$42.02
$42.02
Target
$93.52
$93.52
$67.60
$93.52 avg
$113.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 889.26M | 707.79M | 502.35M |
| Net Income | 162.49M | 116.40M | 88.37M |
| Profit Margin | 18.3% | 17.4% | 17.6% |
| EBITDA | 237.88M | 179.87M | 150.20M |
| Free Cash Flow | — | — | 92.06M |
| Rev Growth | +25.6% | +25.6% | +14.6% |
| Debt/Equity | 0.19 | 0.19 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |